Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.530
-0.010 (-0.65%)
At close: Aug 10, 2026, 4:00 PM EDT
1.493
-0.037 (-2.44%)
After-hours: Aug 10, 2026, 7:34 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.58 million as of August 10, 2026. Its market cap has decreased by -4.37% in one year.
Market Cap
6.58M
Enterprise Value
-2.68M
1-Year Change
-4.37%
Ranking
Category
Stock Price
$1.53
ChartMarket Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.58M, a decrease of -88.51%. That is a compound annual growth rate of -34.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 6.58M | 12.46% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 7.13M |
| Xenetic Biosciences | 7.08M |
| Evogene | 7.03M |
| Niki BioSolutions | 7.02M |
| Alzamend Neuro | 7.00M |
| XTL Biopharmaceuticals | 6.89M |
| Imunon | 6.85M |
| FibroBiologics | 6.53M |